The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.
Cardinal Health (NYSE:CAH) reported its second-quarter earnings for fiscal year 2024, surpassing analyst expectations with an earnings per share (EPS) of $1.93 compared to the forecasted $1.77.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback